| Christopher N Lingard, DMD | |
|
2874 N Carson St Ste 230, Carson City, NV 89706-1684 | |
| (775) 884-2111 | |
| (775) 884-2115 |
| Full Name | Christopher N Lingard |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 2874 N Carson St Ste 230, Carson City, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063668184 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 7006361-9921 (Utah) | Primary |
| 1223G0001X | Dentist - General Practice | 7006361-8903 (Utah) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher N Lingard, DMD 2874 N Carson St Ste 230, Carson City, NV 89706-1684 Ph: (775) 884-2111 | Christopher N Lingard, DMD 2874 N Carson St Ste 230, Carson City, NV 89706-1684 Ph: (775) 884-2111 |
News Archive
A team of researchers from Columbia University Medical Center, Weill Cornell Medical College, and Brandeis University has devised a wholly new approach to the treatment of Alzheimer's disease involving the so-called retromer protein complex. Retromer plays a vital role in neurons, steering amyloid precursor protein (APP) away from a region of the cell where APP is cleaved, creating the potentially toxic byproduct amyloid-beta, which is thought to contribute to the development of Alzheimer's.
Diabetes is a serious health condition that affects millions of people in the United States and has more than doubled in prevalence over the past 20 years.
EpiCept Corporation announced today that it has entered into a definitive agreement with a single life science focused institutional investor for the purchase of 1,065 shares of its new Series B 0% Convertible Preferred Stock at $1,000 per share, which are convertible into an aggregate of approximately 6.3 million shares of its common stock, and five-year warrants to purchase up to approximately 3.1 million shares of its common stock at an exercise price of $0.17 per share that are immediately exercisable.
A study led by Queen Mary University of London researchers has compared the performance and acceptability of a urine test and four different vaginal self-sampling collection devices to detect high risk Human Papilloma Virus (HPV).
› Verified 9 days ago
Dr. Justine Stacey Wong, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 917 Mountain Street, Carson City, NV 89703 Phone: 775-888-6887 | |
Elizabeth Park, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 501 S Division St, Carson City, NV 89703 Phone: 775-882-1195 Fax: 775-882-3037 | |
Iman Nilforushan, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 956 Topsy Ln Ste 103, Carson City, NV 89705 Phone: 775-391-8797 | |
Dr. William J Holmes, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 525 W Washington St, Carson City, NV 89703 Phone: 775-882-4247 Fax: 775-882-8584 | |
Dr. Justine Fong Dupanovic, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1201 N Nevada St, Carson City, NV 89703 Phone: 775-882-2290 | |
Dr. Jared Thomas Buck, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1177 N Division St, Suite #1, Carson City, NV 89703 Phone: 775-883-3434 Fax: 775-885-9985 |